The effect of progressive exercise training on trained middle-aged men

The effect of progressive exercise training on redox status, myeloperoxidase concentration and hematological parameters in trained middle-aged men

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200625047919N1

Enrollment

Registered

2020-08-06

Start date

2020-06-30

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immunity. Other disorders involving the immune mechanism, not elsewhere classified

Interventions

Intervention group (trained): The subjects will perform a session of progressive exercise training on treadmill based on the modified Bruce test and at each stage that they are unable to continue, th

Eligibility

Sex/Gender

Male

Age

50 Years to 59 Years

Inclusion criteria

Inclusion criteria: Have age ranges 50-59 years No consumption of alcohol beverages No taking antioxidant supplements No suffering from chronic diseases No suffering from musculoskeletal injuries No smoking

Exclusion criteria

Exclusion criteria: have cardiovascular and orthopedic disorders

Design outcomes

Primary

Measure	Time frame
Total Antioxidant Capacity. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Total Oxidative State. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Myeloperoxidase. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;White Blood Cells (WBC). Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Neutrophils. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Monocytes. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Lymphocytes. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Eosinophils. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Basophils. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Hematocrit (HCT). Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Hemoglobin (Hgb). Timepoint: Before, immediately	—

Measure

Time frame

Total Antioxidant Capacity. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Total Oxidative State. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Myeloperoxidase. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;White Blood Cells (WBC). Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Neutrophils. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Monocytes. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Lymphocytes. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Eosinophils. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Basophils. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Hematocrit (HCT). Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Hemoglobin (Hgb). Timepoint: Before, immediately

—

Secondary

Measure	Time frame
Blood pressure. Timepoint: Before, immediately and one hour after the end of the intervention. Method of measurement: Using the blood pressure device.;Triglyceride. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;Low-density lipoprotein. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;High-density lipoprotein. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;Cholstrol. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.	—

Measure

Time frame

Blood pressure. Timepoint: Before, immediately and one hour after the end of the intervention. Method of measurement: Using the blood pressure device.;Triglyceride. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;Low-density lipoprotein. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;High-density lipoprotein. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;Cholstrol. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Reza Rahimi Moghaddam

Islamic Azad University

sr_rahimi@yahoo.com+98 13 3342 2153

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026